FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/089030 [Registered on: 18/06/2025] Trial Registered Prospectively
Last Modified On: 08/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study on local Magnesium sulphate injection for neck pain 
Scientific Title of Study   Efficacy of magnesium sulphate in myofascial trigger point injections in chronic neck pain - A randomised controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Binayak Sahu 
Designation  Junior Resident 
Affiliation  AIIMS, New Delhi 
Address  Department of Anaesthesiology, Pain Medicine and Critical Care Room no. 5011, 5th floor, Academic block, AIIMS, New Delhi

South
DELHI
110029
India 
Phone  9348999752  
Fax    
Email  19binayak19@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Dhruv Jain 
Designation  Assistant Professor 
Affiliation  AIIMS, New Delhi 
Address  Department of Anaesthesiology, Pain Medicine and Critical Care Room no. 5008B, 5th floor, Academic block, AIIMS, New Delhi

South
DELHI
110029
India 
Phone  7042129423  
Fax    
Email  dhruvjn@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Dhruv Jain 
Designation  Assistant Professor 
Affiliation  AIIMS, New Delhi 
Address  Department of Anaesthesiology, Pain Medicine and Critical Care Room no. 5008B, 5th floor, Academic block, AIIMS, New Delhi

South
DELHI
110029
India 
Phone  7042129423  
Fax    
Email  dhruvjn@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesiology, Pain Medicine and Critical care, AIIMS, New Delhi, Ansari Nagar East, Pin-110029, India 
 
Primary Sponsor  
Name  Department of Anaesthesiology Pain Medicine and Critical Care AIIMS New Delhi 
Address  Ansari Nagar East,New Delhi , Pin.110029, India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Binayak Sahu  AIIMS, New Delhi  Pain clinic, 4th floor, Rajkumari Amrit Kaur OPD, AIIMS, New Delhi
South
DELHI 
9348999752

19binayak19@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee for Postgraduate Research, AIIMS, New Delhi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M791||Myalgia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Trigger point injection with magnesium and ropivacaine  1ml injectate of 250 mg magnesium sulphate (500mg/ml) and 0.25% ropivacaine will be injected in the trigger point of neck muscle under ultrasound guidance untill twitch is seen in muscle fibre or reproduction of pain occurs. 
Comparator Agent  Trigger point injection with only ropivacaine  1ml injectate of 0.25% ropivacaine will be injected in the trigger point of neck muscle under ultrasound guidance untill twitch is seen in muscle fibre or reproduction of pain occurs. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Neck pain more than 3 months
2.Age more than 18years
3.Definitive diagnosis of myofascial pain syndrome of neck muscles with identification of trigger points defined by presence of one or more taut bands in muscle, focal tenderness within these taut bands, local or referred pain on palpation or gentle snapping palpation elicits a twitch response. 
 
ExclusionCriteria 
Details  1.Patients not giving consent
2.Any painful conditions of neck and back muscles other than myofascial pain syndrome like fibromyalgia, spondylosis, cervical radiculopathy, vertrebrobasilar insufficiency
3.Known allergy to local anaesthetics or magnesium sulphate
4.History of prior invasive procedure in neck muscle 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Numeric Rating Scale for pain  3months 
 
Secondary Outcome  
Outcome  TimePoints 
Numerical Rating Scale for pain  14days and 1month 
Neck movement using goniometer  1month and 3 months 
Pain pressure threshold using algometer  1month and 3months 
Neck disability index  1month and 3 months 
Patient satisfaction score   1month and 3 months 
 
Target Sample Size   Total Sample Size="72"
Sample Size from India="72" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

 

Myofascial pain syndrome is a common problem for chronic neck and back pain in general population. Different treatment modalities like Dry needling, Trigger point injections, Transcutaneous Electrical Nerve Stimulation exists, but among these Trigger Point Injections is widely accepted method. In trigger point iInjections Local anaesthetics, Steroids, Botulinum toxins has been used previously. Recent study shows Magnesium as a new promising alternative. Moreover, Magnesium Sulphate is cheaper, easily available and have lesser side effects when used as an injectate in Trigger Point Injection. Magnesium can be beneficial as it acts as a vasodilator which leads to wash away accumulated toxins like prostaglandin, bradykinin etc. It also acts as muscle relaxant and inhibits pre-synaptic Acetylcholine release from neuromuscular junction and sympathetic junction Therefore, our study aims to  prove that Magnesium Sulphate can be used as an alternative injectate in Trigger Point Injection.

 
Close